KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Intangibles (2016 - 2025)

Historic Intangibles for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $22.3 billion.

  • Amgen's Intangibles fell 1957.83% to $22.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $22.3 billion, marking a year-over-year decrease of 1957.83%. This contributed to the annual value of $22.3 billion for FY2025, which is 1957.83% down from last year.
  • According to the latest figures from Q4 2025, Amgen's Intangibles is $22.3 billion, which was down 1957.83% from $23.1 billion recorded in Q3 2025.
  • Over the past 5 years, Amgen's Intangibles peaked at $32.6 billion during Q4 2023, and registered a low of $13.2 billion during Q3 2023.
  • Its 5-year average for Intangibles is $20.4 billion, with a median of $16.0 billion in 2021.
  • Its Intangibles has fluctuated over the past 5 years, first skyrocketed by 11992.4% in 2024, then tumbled by 1998.96% in 2025.
  • Amgen's Intangibles (Quarter) stood at $15.2 billion in 2021, then grew by 5.91% to $16.1 billion in 2022, then surged by 102.99% to $32.6 billion in 2023, then decreased by 15.14% to $27.7 billion in 2024, then fell by 19.58% to $22.3 billion in 2025.
  • Its last three reported values are $22.3 billion in Q4 2025, $23.1 billion for Q3 2025, and $24.6 billion during Q2 2025.